• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物组-宿主相互作用在慢性阻塞性肺疾病急性加重发病机制中的作用。

Microbiome-host interactions in the pathogenesis of acute exacerbation of chronic obstructive pulmonary disease.

机构信息

Department of Respiratory and Critical Care Medicine, Huaian Clinical College of Xuzhou Medical University, Huaian, China.

Department of Intensive Care Unit, The Affiliated Huaian Hospital of Xuzhou Medical University, Huaian, China.

出版信息

Front Cell Infect Microbiol. 2024 Jul 18;14:1386201. doi: 10.3389/fcimb.2024.1386201. eCollection 2024.

DOI:10.3389/fcimb.2024.1386201
PMID:39091676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11291260/
Abstract

OBJECTIVE

To explore the underlying mechanisms the airway microbiome contributes to Acute Exacerbation of Chronic Obstructive Pulmonary Disease(AECOPD).

METHODS

We enrolled 31 AECOPD patients and 26 stable COPD patients, their sputum samples were collected for metagenomic and RNA sequencing, and then subjected to bioinformatic analyses. The expression of host genes was validated by Quantitative Real-time PCR(qPCR) using the same batch of specimens.

RESULTS

Our results indicated a higher expression of (=0.015) in the AECOPD group and (=0.005) in the COPD group. The Different expressed genes(DEGs) detected were significantly enriched in "type I interferon signaling pathway"(<0.001, =0.001) in gene function annotation, and "Cytosolic DNA-sensing pathway"(=0.002, =0.024), "Toll-like receptor signaling pathway"(=0.006, =0.045), and "TNF signaling pathway"(=0.006, =0.045) in KEGG enrichment analysis. qPCR amplification experiment verified that the expression of and increased significantly in the AECOPD group.

CONCLUSION

Pulmonary bacteria dysbiosis may regulate the pathogenesis of AECOPD through innate immune system pathways like type I interferon signaling pathway and Toll-like receptor signaling pathway.

摘要

目的

探索气道微生物组在慢性阻塞性肺疾病急性加重(AECOPD)中的作用机制。

方法

我们招募了 31 名 AECOPD 患者和 26 名稳定期 COPD 患者,收集他们的痰标本进行宏基因组和 RNA 测序,并进行生物信息学分析。使用相同批次的标本通过定量实时 PCR(qPCR)验证宿主基因的表达。

结果

我们的结果表明,AECOPD 组的表达较高(=0.015),COPD 组的表达较高(=0.005)。检测到的差异表达基因(DEGs)在基因功能注释中显著富集于“I 型干扰素信号通路”(<0.001,=0.001),KEGG 富集分析中还显著富集于“胞质 DNA 感应途径”(=0.002,=0.024)、“Toll 样受体信号通路”(=0.006,=0.045)和“TNF 信号通路”(=0.006,=0.045)。qPCR 扩增实验验证了 AECOPD 组中表达显著增加。

结论

肺部细菌失调可能通过 I 型干扰素信号通路和 Toll 样受体信号通路等先天免疫系统途径调节 AECOPD 的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/741c76f5da48/fcimb-14-1386201-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/d746a0a62eb4/fcimb-14-1386201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/f4e518b59e5b/fcimb-14-1386201-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/e8702a62d734/fcimb-14-1386201-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/e5de19280f05/fcimb-14-1386201-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/d02434900c21/fcimb-14-1386201-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/1d3a91ff6ba2/fcimb-14-1386201-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/ec4defc65026/fcimb-14-1386201-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/741c76f5da48/fcimb-14-1386201-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/d746a0a62eb4/fcimb-14-1386201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/f4e518b59e5b/fcimb-14-1386201-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/e8702a62d734/fcimb-14-1386201-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/e5de19280f05/fcimb-14-1386201-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/d02434900c21/fcimb-14-1386201-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/1d3a91ff6ba2/fcimb-14-1386201-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/ec4defc65026/fcimb-14-1386201-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf0/11291260/741c76f5da48/fcimb-14-1386201-g008.jpg

相似文献

1
Microbiome-host interactions in the pathogenesis of acute exacerbation of chronic obstructive pulmonary disease.微生物组-宿主相互作用在慢性阻塞性肺疾病急性加重发病机制中的作用。
Front Cell Infect Microbiol. 2024 Jul 18;14:1386201. doi: 10.3389/fcimb.2024.1386201. eCollection 2024.
2
Airway host-microbiome interactions in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的气道宿主-微生物组相互作用。
Respir Res. 2019 Jun 6;20(1):113. doi: 10.1186/s12931-019-1085-z.
3
A metagenomic next-generation sequencing (mNGS)-based analysis of bronchoalveolar lavage samples in patients with an acute exacerbation of chronic obstructive pulmonary disease.基于宏基因组下一代测序(mNGS)的慢性阻塞性肺疾病急性加重患者支气管肺泡灌洗液样本分析。
J Mol Histol. 2024 Oct;55(5):709-719. doi: 10.1007/s10735-024-10225-1. Epub 2024 Jul 26.
4
Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.COPD 加重期痰液微生物组特征及其与临床指标的相关性。
J Transl Med. 2022 Feb 5;20(1):76. doi: 10.1186/s12967-022-03278-x.
5
The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable .COPD 中免疫反应与细菌感染的相互作用:聚焦于不可分型。
Front Immunol. 2018 Nov 5;9:2530. doi: 10.3389/fimmu.2018.02530. eCollection 2018.
6
Antagonistic Pleiotropy in the Bifunctional Surface Protein FadL (OmpP1) during Adaptation of Haemophilus influenzae to Chronic Lung Infection Associated with Chronic Obstructive Pulmonary Disease.双功能表面蛋白 FadL(OmpP1)在流感嗜血杆菌适应与慢性阻塞性肺疾病相关的慢性肺部感染中的拮抗多效性。
mBio. 2018 Sep 25;9(5):e01176-18. doi: 10.1128/mBio.01176-18.
7
Transcriptomic analysis and validation reveal the pathogenesis and a novel biomarker of acute exacerbation of chronic obstructive pulmonary disease.转录组分析和验证揭示了慢性阻塞性肺疾病急性加重的发病机制和一个新的生物标志物。
Respir Res. 2022 Feb 12;23(1):27. doi: 10.1186/s12931-022-01950-w.
8
The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.慢性阻塞性肺疾病急性加重期的痰液微生物组
Ann Am Thorac Soc. 2015 Nov;12 Suppl 2(Suppl 2):S176-80. doi: 10.1513/AnnalsATS.201506-319AW.
9
Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function.通过定量聚合酶链反应和培养法测定稳定期慢性阻塞性肺疾病患者气道细菌:与中性粒细胞性气道炎症、急性加重频率及肺功能的关系
Int J Chron Obstruct Pulmon Dis. 2015 Jun 9;10:1075-83. doi: 10.2147/COPD.S80091. eCollection 2015.
10
Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.急性加重期和稳定期慢性阻塞性肺疾病粪便微生物特征的变化。
Life Sci. 2021 Jan 15;265:118738. doi: 10.1016/j.lfs.2020.118738. Epub 2020 Nov 10.

本文引用的文献

1
Responsiveness to pulmonary rehabilitation in COPD is associated with changes in microbiota.COPD 对肺康复的反应与微生物群的变化有关。
Respir Res. 2023 Jan 25;24(1):29. doi: 10.1186/s12931-023-02339-z.
2
Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions.多组学分析慢性阻塞性肺疾病气道宿主-微生物相互作用,确定潜在的治疗干预措施。
Nat Microbiol. 2022 Sep;7(9):1361-1375. doi: 10.1038/s41564-022-01196-8. Epub 2022 Aug 22.
3
Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.
慢性阻塞性肺疾病患者与健康个体的肺部微生物群组成及支气管上皮基因表达:细菌16S rRNA基因测序和宿主转录组分析
Lancet Microbe. 2021 Jul;2(7):e300-e310. doi: 10.1016/S2666-5247(21)00035-5. Epub 2021 Apr 23.
4
Chronic obstructive pulmonary disease.慢性阻塞性肺疾病。
Lancet. 2022 Jun 11;399(10342):2227-2242. doi: 10.1016/S0140-6736(22)00470-6. Epub 2022 May 6.
5
IL-6 and IL-10 Are Associated With Gram-Negative and Gram-Positive Bacteria Infection in Lymphoma.IL-6 和 IL-10 与淋巴瘤中革兰氏阴性菌和革兰氏阳性菌感染有关。
Front Immunol. 2022 Apr 1;13:856039. doi: 10.3389/fimmu.2022.856039. eCollection 2022.
6
Exploring the Change of Host and Microorganism in Chronic Obstructive Pulmonary Disease Patients Based on Metagenomic and Metatranscriptomic Sequencing.基于宏基因组学和宏转录组学测序探索慢性阻塞性肺疾病患者宿主与微生物的变化
Front Microbiol. 2022 Mar 16;13:818281. doi: 10.3389/fmicb.2022.818281. eCollection 2022.
7
Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.COPD 加重期痰液微生物组特征及其与临床指标的相关性。
J Transl Med. 2022 Feb 5;20(1):76. doi: 10.1186/s12967-022-03278-x.
8
Nasopharyngeal metatranscriptome profiles of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study.婴儿毛细支气管炎与儿童哮喘风险的鼻咽转录组特征:一项多中心前瞻性研究。
Eur Respir J. 2022 Jul 13;60(1). doi: 10.1183/13993003.02293-2021. Print 2022 Jul.
9
A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis.微小 RNA-21 介导的 SATB1/S100A9/NF-κB 轴促进慢性阻塞性肺疾病发病机制。
Sci Transl Med. 2021 Nov 24;13(621):eaav7223. doi: 10.1126/scitranslmed.aav7223.
10
is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease.是慢性肺病患者呼吸道中的一种抗炎细菌。
Eur Respir J. 2022 May 5;59(5). doi: 10.1183/13993003.01293-2021. Print 2022 May.